Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort’s most advanced product candidate, XP13512, is the subject of this announced alliance with GSK. XenoPort also has a second product candidate, XP19986. Positive Phase IIa results have been reported in patients with Gastroesophageal Reflux Disease (GERD) with XP19986. ( www.xenoport.com )
XenoPort , Inc.
3410 Central Expressway
Santa Clara, California 95051
USA
Tel: (408) 616-7200
Fax: (408) 616-7210